149 related articles for article (PubMed ID: 35165917)
1. Optimal adaptive promising zone designs.
Mehta C; Bhingare A; Liu L; Senchaudhuri P
Stat Med; 2022 May; 41(11):1950-1970. PubMed ID: 35165917
[TBL] [Abstract][Full Text] [Related]
2. Sample size adjustment designs with time-to-event outcomes: A caution.
Freidlin B; Korn EL
Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
[TBL] [Abstract][Full Text] [Related]
3. Optimal flexible sample size design with robust power.
Zhang L; Cui L; Yang B
Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
[TBL] [Abstract][Full Text] [Related]
4. Optimal promising zone designs.
Hsiao ST; Liu L; Mehta CR
Biom J; 2019 Sep; 61(5):1175-1186. PubMed ID: 30411405
[TBL] [Abstract][Full Text] [Related]
5. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.
Levin GP; Emerson SC; Emerson SS
Stat Med; 2013 Apr; 32(8):1259-75; discussion 1280-2. PubMed ID: 23081665
[TBL] [Abstract][Full Text] [Related]
6. Adaptive trial designs.
Lai TL; Lavori PW; Shih MC
Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
[TBL] [Abstract][Full Text] [Related]
7. Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive power.
Liu Q; Hu G; Ye B; Wang S; Wu Y
Pharm Stat; 2023 Mar; 22(2):349-364. PubMed ID: 36418025
[TBL] [Abstract][Full Text] [Related]
8. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Ryan EG; Brock K; Gates S; Slade D
BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
[TBL] [Abstract][Full Text] [Related]
9. Adaptive sample size modification in clinical trials: start small then ask for more?
Jennison C; Turnbull BW
Stat Med; 2015 Dec; 34(29):3793-810. PubMed ID: 26172385
[TBL] [Abstract][Full Text] [Related]
10. Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.
Wang Y; Travis J; Gajewski B
BMC Med Res Methodol; 2022 Apr; 22(1):118. PubMed ID: 35448963
[TBL] [Abstract][Full Text] [Related]
11. Optimal adaptive group sequential design with flexible timing of sample size determination.
Cui L; Zhang L; Yang B
Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
[TBL] [Abstract][Full Text] [Related]
12. Promising zone two-stage design for a single-arm study with binary outcome.
Shan G
Stat Methods Med Res; 2023 Jun; 32(6):1159-1168. PubMed ID: 36998163
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.
Jacob L; Uvarova M; Boulet S; Begaj I; Chevret S
BMC Med Res Methodol; 2016 Jun; 16():67. PubMed ID: 27250349
[TBL] [Abstract][Full Text] [Related]
14. Bayesian basket trial design with false-discovery rate control.
Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
[TBL] [Abstract][Full Text] [Related]
15. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
Herrmann C; Pilz M; Kieser M; Rauch G
Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
[TBL] [Abstract][Full Text] [Related]
16. Sample size re-estimation in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD
Stat Methods Med Res; 2019 Jun; 28(6):1852-1878. PubMed ID: 29869564
[TBL] [Abstract][Full Text] [Related]
17. Stepwise two-stage sample size adaptation.
Wan H; Ellenberg SS; Anderson KM
Stat Med; 2015 Jan; 34(1):27-38. PubMed ID: 25252082
[TBL] [Abstract][Full Text] [Related]
18. Improving clinical trials using Bayesian adaptive designs: a breast cancer example.
Hong W; McLachlan SA; Moore M; Mahar RK
BMC Med Res Methodol; 2022 May; 22(1):133. PubMed ID: 35508968
[TBL] [Abstract][Full Text] [Related]
19. Conditional estimation in two-stage adaptive designs.
Broberg P; Miller F
Biometrics; 2017 Sep; 73(3):895-904. PubMed ID: 28099993
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian sequential design with binary outcome.
Zhu H; Yu Q; Mercante DE
Pharm Stat; 2017 May; 16(3):192-200. PubMed ID: 28251815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
